Page last updated: 2024-08-23

s-adenosylmethionine and gemcitabine

s-adenosylmethionine has been researched along with gemcitabine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bi, T; Gao, Q; Liu, L; Liu, Y; Qin, L; Shen, G	1

Other Studies

1 other study(ies) available for s-adenosylmethionine and gemcitabine

Article	Year
S-Adenosylmethionine synergistically enhances the antitumor effect of gemcitabine against pancreatic cancer through JAK2/STAT3 pathway. Naunyn-Schmiedeberg's archives of pharmacology, 2019, Volume: 392, Issue:5 Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Survival; Deoxycytidine; Drug Synergism; Female; Gemcitabine; Humans; Janus Kinase 2; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; S-Adenosylmethionine; Signal Transduction; STAT3 Transcription Factor; Tumor Burden	2019

Article

Year

S-Adenosylmethionine synergistically enhances the antitumor effect of gemcitabine against pancreatic cancer through JAK2/STAT3 pathway.

Naunyn-Schmiedeberg's archives of pharmacology, 2019, Volume: 392, Issue:5

Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Survival; Deoxycytidine; Drug Synergism; Female; Gemcitabine; Humans; Janus Kinase 2; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; S-Adenosylmethionine; Signal Transduction; STAT3 Transcription Factor; Tumor Burden

2019